Helpful Insights forPatients and Caregivers

Harm Reduction for People Who Use Drugs (PWUD)

Download PDF

Harm reduction is meant to reduce the negative effects of harmful drug use by providing social, health, and/or job services even if the person receiving these services continues substance use.

References

  1. Hawk M, Coulter RWS, Egan JE, et al. Harm reduction principles for healthcare settings. Harm Reduct J. 2017;14(1):70. Published 2017 Oct 24. doi:10.1186/s12954-017-0196-4
  2. Ivers JH, Killeen N, Keenan E. Drug use, harm-reduction practices and attitudes toward the utilisation of drug safety testing services in an Irish cohort of festival-goers. Ir J Med Sci. 2022;191(4):1701-1710. doi:10.1007/s11845-021-02765-2
  3. Wodak A, Maher L. The effectiveness of harm reduction in preventing HIV among injecting drug users. N S W Public Health Bull. 2010;21(3-4):69-73. doi:10.1071/NB10007
  4. Strathdee SA, Ricketts EP, Huettner S, et al. Facilitating entry into drug treatment among injection drug users referred from a needle exchange program: Results from a community-based behavioral intervention trial. Drug Alcohol Depend. 2006;83(3):225-232. doi:10.1016/j.drugalcdep.2005.11.015
  5. Larimer ME, Malone DK, Garner MD, et al. Health care and public service use and costs before and after provision of housing for chronically homeless persons with severe alcohol problems. JAMA. 2009;301(13):1349-1357. doi:10.1001/jama.2009.414
  6. Hawk M, Davis D. The effects of a harm reduction housing program on the viral loads of homeless individuals living with HIV/AIDS. AIDS Care. 2012;24(5):577-582. doi:10.1080/09540121.2011.630352
  7. Maghsoudi N, Tanguay J, Scarfone K, et al. Drug checking services for people who use drugs: a systematic review. Addiction. 2022;117(3):532-544. doi:10.1111/add.15734
  8. Wallace B, van Roode T, Pagan F, Hore D, Pauly B. The potential impacts of community drug checking within the overdose crisis: qualitative study exploring the perspective of prospective service users. BMC Public Health. 2021;21(1):1156. Published 2021 Jun 16. doi:10.1186/s12889-021-11243-4
  9. McClellan C, Lambdin BH, Ali MM, et al. Opioid-overdose laws association with opioid use and overdose mortality. Addict Behav. 2018;86:90-95. doi:10.1016/j.addbeh.2018.03.014
  10. West B, Varacallo M. Good Samaritan Laws. In: StatPearls. Treasure Island (FL): StatPearls Publishing; September 20, 2021.
  11. Razaghizad A, Windle SB, Filion KB, et al. The effect of overdose education and naloxone distribution: An umbrella review of systematic reviews. Am J Public Health. 2021;111(8):e1-e12. doi:10.2105/AJPH.2021.306306
  12. Ma J, Bao YP, Wang RJ, et al. Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis. Mol Psychiatry. 2019;24(12):1868-1883. doi:10.1038/s41380-018-0094-5
  13. Jakubowski A, Fox A. Defining Low-threshold Buprenorphine Treatment. J Addict Med. 2020;14(2):95-98. doi:10.1097/ADM.0000000000000555
  14. Terplan M, Hand DJ, Hutchinson M, et al. Contraceptive use and method choice among women with opioid and other substance use disorders: A systematic review. Prev Med. 2015;80:23-31. doi:10.1016/j.ypmed.2015.04.008
  15. Schillie S, Vellozzi C, Reingold A, et al. Prevention of hepatitis b virus infection in the United States: recommendations of the advisory committee on immunization practices. MMWR Recomm Rep. 2018;67(1):1-31. Published 2018 Jan 12. doi:10.15585/mmwr.rr6701a1
  16. Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021;70(4):1-187. Published 2021 Jul 23. doi:10.15585/mmwr.rr7004a1
  17. Centers for Disease Control and Prevention: US Public Health Service: Preexposure prophylaxis for the prevention of HIV infection in the United States—2021 Update: a clinical practice guideline. https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2021.pdf. Published 2021
  18. Samuels EA, Bailer DA, Yolken A. Overdose prevention centers: An essential strategy to address the overdose crisis. JAMA Netw Open. 2022;5(7):e2222153. Published 2022 Jul 1. doi:10.1001/jamanetworkopen.2022.22153
  19. Bolívar HA, Klemperer EM, Coleman SRM, et al. Contingency management for patients receiving medication for opioid use disorder: A systematic review and meta-analysis. JAMA Psychiatry. 2021;78(10):1092. doi:10.1001/jamapsychiatry.2021.1969
  20. Ivsins A, Boyd J, Beletsky L, McNeil R. Tackling the overdose crisis: The role of safe supply. Int J Drug Policy. 2020;80:102769. doi:10.1016/j.drugpo.2020.102769
  21. Buffington DE, Lozicki A, Alfieri T, Bond TC. Understanding factors that contribute to the disposal of unused opioid medication. J Pain Res. 2019;12:725-732. Published 2019 Feb 19. doi:10.2147/JPR.S171742
  22. Stubbings J, Crawford SY, Menighan TE. A safe in-home disposal system with every opioid prescription? Food and Drug Administration is considering a potential new Risk Evaluation and Mitigation Strategy that could impact pharmacists. J Am Pharm Assoc. 2022;62(2):413-418. doi:10.1016/j.japh.2021.11.00
  23. Hurley EA, Goggin K, Piña-Brugman K, et al. Contraception use among individuals with substance use disorder increases tenfold with patient-centered, mobile services: a quasi-experimental study. Harm Reduct J. 2023;20(1):28. doi:10.1186/s12954-023-00760-7
  24. Nelson NP, Weng MK, Hofmeister MG, et al. Prevention of hepatitis a virus infection in the United States: Recommendations of the advisory committee on immunization practices, 2020 [published correction appears in MMWR Morb Mortal Wkly Rep. 2021 Feb 26;70(8):294]. MMWR Recomm Rep. 2020;69(5):1-38. Published 2020 Jul 3. doi:10.15585/mmwr.rr6905a1